(AGTC) - Earnings & Price History

AGTC: - 3.5, $63.30M, 0.10 (2.94%)

Sector: Healthcare - Industry: Biotechnology

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops genetic therapies to treat patients with inherited diseases. Its lead products consist of four ophthalmology development programs across three targets, including X linked retinoschisis (XLRS) that is in a Phase I/II clinical trials for the treatment of an inherited retinal disease; X-linked retinitis pigmentosa (XLRP), which is enrolling patients in a Phase I/II clinical trials; and achromatopsia (ACHM) that is enrolling patients in a Phase I/II clinical trials. Applied Genetic Technologies Corporation has collaboration agreements with Biogen MA, Inc.; 4D Molecular Therapeutics; and Synpromics Limited. The company was founded in 1999 and is headquartered in Alachua, Florida.Key Statistics

Past AGTC reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-02-08AMC0.026.856.46.56.47.181.56%5.38%7.03%343.97K
2016-11-08AMC-0.089.157.0587.79.313.48%▲14.37%29.79%522.43K
2016-09-12AMC0.07913.199.088.779.5-31.16%-0.88%-31.77%2.18M
2016-05-09AMC0.0514.0514.215.0113.8915.925.70%-6.40%-1.06%187.67K
2016-02-08AMC-0.1912.0613.113.2311.1414.610.99%-8.84%-7.94%296.98K
2015-11-05AMC-0.213.0213.1911.6710.8913.17-11.52%▲11.57%-1.29%144.26K
2015-09-10AMC-0.4113.8815.5115.0213.715.11-3.16%-7.59%-10.51%297.83K
2014-12-26Applied Gen Tec-0.29-0.342121.1921.6820.7422.232.31%▲-3.14%-0.90%63.40K

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades